Exelixis (EXEL) EBITDA Margin (2010 - 2026)
Exelixis (EXEL) recorded quarterly EBITDA Margin of 41.15% in Q2 2026, up 4.73% quarter-over-quarter from 39.29% in Q1 2026, and up 751.0% on a YoY basis from 4.84% in Q2 2025.
Exelixis (EXEL) EBITDA Margin (2010 - 2026) Analysis & Trends
Exelixis' EBITDA Margin history runs 17 years deep, the most recent figure standing at 41.15% for Q2 2026.
- In Q2 2026, EBITDA Margin rose 751.0% year-over-year to 41.15%; the TTM figure through Apr 2026 stood at 39.43% (up 628.0% YoY), while the FY2026 annual figure was 37.59%, up 971.0% from the prior year.
- EBITDA Margin was 41.15% for Q2 2026 at Exelixis, up from 39.29% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 43.3% in Q2 2024 to a low of 11.34% in Q4 2022.
- Historically, EBITDA Margin has averaged 22.62% across 5 years, with a median of 23.38% in 2022.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin sank 2379 bps in 2023, then soared 2895 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 11.34% in 2022, then jumped by 250 bps to 17.05% in 2023, then jumped by 48 bps to 25.22% in 2024, then jumped by 57 bps to 39.57% in 2025, then grew by 4 bps to 41.15% in 2026.
- The last three EBITDA Margin figures came in at 41.15% (Q2 2026), 39.29% (Q1 2026), and 39.57% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 41.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 41.15% |
| Jan 2, 2026 | 39.29% |
| Oct 3, 2025 | 39.57% |
| Jul 4, 2025 | 37.58% |
| Apr 4, 2025 | 33.64% |
| Jan 3, 2025 | 28.80% |
| Sep 27, 2024 | 25.22% |
| Jun 28, 2024 | 43.30% |
| Mar 29, 2024 | 6.93% |
| Dec 29, 2023 | 17.05% |
| Sep 29, 2023 | -3.73% |
| Jun 30, 2023 | 16.57% |
| Mar 31, 2023 | 7.05% |
| Dec 30, 2022 | -11.34% |
| Sep 30, 2022 | 20.06% |
| Jul 1, 2022 | 19.96% |
| Apr 1, 2022 | 23.38% |
| Oct 1, 2021 | 15.72% |
| Jul 2, 2021 | 31.94% |
| Apr 2, 2021 | -1.70% |